Momen Natalie C, Ernst Andreas, Arendt Linn Håkonsen, Olsen Jørn, Li Jiong, Gissler Mika, Rasmussen Finn, Ramlau-Hansen Cecilia Høst
Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
PLoS One. 2017 Mar 6;12(3):e0173355. doi: 10.1371/journal.pone.0173355. eCollection 2017.
Several studies on pregnancy-associated cancers have suggested an association with congenital anomalies in offspring. Previous studies have included maternal cancers diagnosed up to 2 years after pregnancy; however, long latency periods of some cancers mean that cancers diagnosed many years postpartum might have been present during pregnancy in a preclinical state. This paper considers the association between maternal cancers diagnosed from 2 years prior to pregnancy until the mother reaches 50 years of age, and congenital anomalies, as diagnosed at birth or within the first year of life. The current population-based study looks at associations of cancers in mothers with congenital anomalies in their children. Children were followed up from birth to diagnosis of a congenital anomaly, death, emigration or end of follow-up (whichever occurred first). A total of 56,016 children (2.6%) were considered exposed to a maternal cancer of any type; and they had a hazard ratio (HR) of 1.04 (95% confidence interval [CI]: 1.00, 1.09) compared with unexposed children. The greatest HR was seen among children whose mothers had been diagnosed with cancers before or during pregnancy (HR: 1.37, 95% CI: 1.07, 1.75). Similar results were seen when paternal cancers were used as a 'negative control'. Statistically significant associations were seen for some specific congenital anomalies of organ systems (congenital anomalies of the musculoskeletal system [HR: 1.13, 95% CI: 1.02, 1.25]) and for some specific types of maternal cancer (leukaemia [HR: 1.31, 95% CI: 1.01, 1.61], The results of the main analyses suggest a small increase in risk of congenital anomalies in offspring of mothers diagnosed with cancer from 2 years before pregnancy, until the mother reaches 50 years of age; with the greatest increase seen for exposure in the pre-pregnancy and pregnancy period. These results may reflect shared causes for some cancers and some congenital anomalies. The similar results seen for paternal cancers indicate that the cause may be genetic or related to the families' social and environmental conditions.
多项关于妊娠相关癌症的研究表明,其与后代先天性异常有关。既往研究纳入了妊娠后2年内诊断出的母亲癌症病例;然而,一些癌症的潜伏期较长,这意味着产后多年诊断出的癌症在孕期可能处于临床前状态。本文探讨了从妊娠前2年至母亲年满50岁期间诊断出的母亲癌症与出生时或出生后第一年内诊断出的先天性异常之间的关联。当前这项基于人群的研究着眼于母亲患癌与子女先天性异常之间的关联。对儿童从出生开始进行随访,直至诊断出先天性异常、死亡、移民或随访结束(以先发生者为准)。共有56,016名儿童(2.6%)被视为暴露于任何类型的母亲癌症;与未暴露儿童相比,他们的风险比(HR)为1.04(95%置信区间[CI]:1.00,1.09)。母亲在怀孕前或怀孕期间被诊断出患有癌症的儿童风险比最高(HR:1.37,95%CI:1.07,1.75)。当将父亲患癌作为“阴性对照”时,也观察到了类似结果。对于器官系统的一些特定先天性异常(肌肉骨骼系统先天性异常[HR:1.13,95%CI:1.02,1.25])以及某些特定类型的母亲癌症(白血病[HR:1.31,95%CI:1.01,1.61]),观察到了具有统计学意义的关联。主要分析结果表明,从妊娠前2年直至母亲年满50岁期间被诊断出患癌的母亲,其后代先天性异常风险略有增加;在怀孕前和怀孕期间暴露的情况下增加最为明显。这些结果可能反映了某些癌症和某些先天性异常的共同病因。父亲患癌时观察到的类似结果表明,病因可能是遗传因素或与家庭的社会和环境状况有关。